Antiinflammatory activity of 2-, 3-, 4-carboxymethylpyridinium hexafluorosilicates on carrageenan model of inflammation
Journal Title: Фармацевтичний журнал - Year 2019, Vol 4, Issue 4
Abstract
In the last decade, high cariesprophylactic efficacy of ammonium hexafluorosilicates, including salts with substituted biologically active ammonium cations, has been demonstrated. Among the promising anti-caries agents are recently synthesized 2-, 3-, 4-carboxymethylpyridinium hexafluorosilicates, for whose cations anti-inflammatory activity is expected. The aim of the work is to assess the presence of anti-inflammatory activity in the series of 2-, 3-, 4-carboxymethylpyridinium hexafluorosilicates in the experiment. 2-, 3-, 4-Carboxymethylpyridinium hexafluorosilicates (I–III, respectively) were synthesized according to the previously proposed technique, carrageenan is a commercial preparation, reference drug is a indomethacin. Experiments on the anti-inflammatory activity of hexafluorosilicates were performed on 77 white Wistar male rats weighing 174–190 g using the carrageenan model of inflammation. The inflammatory reaction was reproduced by subplantary administration of 0.1 ml of a 0.2% solution of carrageenan, the studied compounds were administered orally in doses 1/10, 1/20, 1/50 from LD50 for the compound III. It was established that after administration of carrageenan, animals of the control group showed marked paw edema, which gradually increased and was maximal after 24 hours of observation. According to the data obtained, the indices for compounds I-III practically do not differ from those of the control group. This indicates that, despite the results of the PASS forecast and the presence of acetic acid residue, an anti-inflammatory pharmacofor, in compounds I-III, the compounds under study do not have an anti-inflammatory effect in the carrageenan model. 2-, 3-, 4-Carboxymethylpyridinium hexafluorosilicates do not show the expected anti-inflammatory activity in the carrageenan model of inflammation.
Authors and Affiliations
B. V. Pristupa, I. O. Shyshkin, Ya. V. Rozhkovsky, V. O. Gelmboldt
Keywords
Related Articles
- EP ID EP635543
- DOI 10.32352/0367-3057.4.19.09
- Views 80
- Downloads 0
Structural and adsorptive properties of silica-alumina and clay materials of mineral and synthetic origin
Location on territory of Ukraine of great deposits of aluminosilicates together with good facilities for their processing and standardization promotes the study of this raw material, results of which could be useful for...
Hypoglycemic activity of Citrullus colocynthis (L.) Shrad. dry extract
Phytotherapyof diabetes mellitus has several advantages over his chemotherapy: a wide range of biologically active substances, complex and physiological effects on the organism, low toxicity. That is why the search for e...
Seamless access for the handicapped persons to pharmacy chain on principles of pharmaceutical law
The problem of access of citizens and patients with disabilities (wheelchair users) to the establishments of the pharmacy chain is relevant. The aim of the work was to examine the causes which prevent unimpeded access o...
Research of influence of pharmaceutical factors on the process of creation of pills with the operating substance of a 1 class of BSС on the example of bisoprolol fumarate
Among the diseases of population of Ukraine and world the first place is occupied by the diseases of the cardiovascular system. The evidential base of efficiency of application of b-blockers at the different forms of isc...
Spasmolytic medicines for treatment of cholelithiasis at Ukrainian pharmaceutical market
The prevalence of cholelithiasis among 100 000 adult people is increasing in a stable way. From 2001 to 2010 the morbidity of cholelithiasis raised to 32.7%, but frequency of this disease revealed for the first time went...